Nova Biomedical Launches Stat EMS Basic in CE Mark Countries

WALTHAM, Mass. - April 16, 2020 - PRLog -- Nova Biomedical is pleased to announce the launch of the Stat EMS Basic blood testing system for ambulance and emergency care in CE mark countries. Stat EMS Basic measures fingerstick capillary lactate, glucose, ketone, hemoglobin, and hematocrit in six to 40 seconds with laboratory-quality results.

Stat EMS Basic is a smaller, non-connectivity version of Nova's connectivity-capable Stat EMS system with the same test menu. Stat EMS Basic combines battery-operated StatStrip Xpress2 meters in a new, lightweight soft case that easily fits in a medic's bag while holding all system components: meters, test strips, controls, and lancets. Test strips and controls require no refrigeration, making testing convenient and economical.

Specifically designed for ambulance, pre-hospital, and emergency use, Stat EMS Basic provides an important test menu and rapid results to aid with patient assessment and allow for faster, more effective emergency treatment. Stat EMS Basic also assists with rapid triage and determining the appropriate transport site for patients who have trauma, sepsis, anemia, acute coronary syndrome, or other critical illnesses.

Stat EMS Basic meters use Nova's patented, disposable test strips that provide lab-like

accuracy, including the only lactate test strip cleared for fingerstick testing and the only glucose test strip proven accurate enough to have been cleared by the U.S. Food and Drug Administration for use with critically ill patients—and used in thousands of hospitals worldwide.

Stat EMS Basic meters are easy to use; there is no calibration or coding and the testing procedure is as simple as fingerstick glucose testing performed by people with diabetes. Tiny capillary samples eliminate the need for venipuncture, saving time and reducing costs.

About Nova Biomedical

Incorporated in 1976 and based in Waltham, MA, Nova Biomedical is a world leader in the development and manufacturing of state-of-the-art, whole blood, point-of-care and critical care analyzers, as well as providing the biotechnology industry with the most advanced instruments for cell culture monitoring. Nova is one of the fastest growing in vitro diagnostic companies in the world. Nova's test strip technology is incorporated in products ranging from handheld meters for glucose self- and point-of-care testing to critical care whole blood analyzers designed for rapid measurement of over 20 analytes. Over half of all U.S. hospitals use Nova's critical care products. Nova employs over 1,300 people worldwide and has wholly owned subsidiaries located in Brazil, Canada, France, Germany, Great Britain, Italy, Japan, Spain, Switzerland, and Taiwan.

http://www.novabiomedical.com